Transition Bio

Transition Bio

Biotechnology, 810 Avenw, Cambridge, Massachusetts, Vermont, 20420, United States, 11-50 Employees

transitionbio.com

  • LinkedIn

Who is TRANSITION BIO

Transition Bio is developing one-of-a-kind technologies for biomolecular condensate analysis. Through our Condensomics platform, our goal is to build a drug discovery engine based on the ...

Read More

map
  • 810 Vermont Avenw, Cambridge, Massachusetts, 20420, United States Headquarters: 810 Vermont Avenw, Cambridge, Massachusetts, 20420, United States
  • 1930 Date Founded: 1930
  • 11-50 Employees: 11-50
  • dollar-icon Revenue: $1 Billion and Over
  • tech-icon Active Tech Stack: See technologies

industries-icon Industry: Biotechnology

SIC SIC Code: 8011 | NAICS Code: 923140 | Show More

checked-icon Does something look wrong? Fix it. | View contact records from TRANSITION BIO

Transition Bio Org Chart and Mapping

Employees

Gale Rudlaff

Editing Scientist II, Discovery Biology

Prathima Radhakrishnan

Scientist, Microscopy-Based Cellular Assays

Julia D

Scientist II, Discovery Biology

Charlotte Kelley

Scientist, Molecular and Cellular Condensate Biology

signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding Transition Bio

Answer: Transition Bio's headquarters are located at 810 Avenw, Cambridge, Massachusetts, Vermont, 20420, United States

Answer: Transition Bio's official website is https://transitionbio.com

Answer: Transition Bio's revenue is $1 Billion and Over

Answer: Transition Bio's SIC: 8011

Answer: Transition Bio's NAICS: 923140

Answer: Transition Bio has 11-50 employees

Answer: Transition Bio is in Biotechnology

Answer: Transition Bio contact info: Phone number: Website: https://transitionbio.com

Answer: Transition Bio is developing one-of-a-kind technologies for biomolecular condensate analysis. Through our Condensomics platform, our goal is to build a drug discovery engine based on the latest advancements in biophysics and artificial intelligence. We harness droplet microfluidic approaches and cellular platforms to characterize condensates with unprecedented scale and precision, resulting in the mapping of condensates and their modulation, in molecular detail. Our proprietary datasets feed in to algorithms that we use for target discovery, target validation and drug design.

Answer:

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access